Read the IMI interview with HARMONY Partners Jan
@HARMONY Talks: Partners, Work Package Leaders and Leaders
@HARMONY Talks: Partners, Work Package Leaders and Leaders
HARMONY presented at the Fifth Annual Life Science R&D Data
EU’s Health Commissioner Andriukaitis: Big data has ‘enormous’ ...
HARMONY in the new open access journal of the European Hematology ...
Advancing a field by building consortia: The example of the
We are looking forward to another exciting and productive
Wishing you a Healthy and Prosperous 2018!
What is a health outcome? View and listen to the ICHOM video. ...
HARMONY Networking at ASH2017, the 59th Annual Meeting and Exposition ...
Connecting at the 1st European Alliance for Personalised Medicine ...
Making Change Happen in Health: Harnessing the Benefits of Science ...
Summarizing the HARMONY Workshop on the Definition of Meaningful ...
HARMONY at the 59th Annual Meeting of the American Society of ...
HARMONY Work Packages 2 & 6 Leadership in action in London,
Part 1: Offering in-depth Interviews to learn more about the ...
Part 2: Offering in-depth Interviews to learn more about the ...
The HARMONY Alliance is an unparalleled medicine offensive
Data Sharing from Clinical Trials: A Research Funder’s ...
HARMONY at the 1st European Alliance for Personalised Medicine ...
IPSOR: Including the Patient Perspective in Health Care Decision ...
New IMI brochure ‘Carry the torch’ highlighting
HARMONY
Healthcare Alliance for Resourceful Medicine Offensive against Neoplasms in Hematology
Funded through the Innovative Medicines Initiative (IMI) 2 Joint Undertaking and listed under grant agreement No. 116026. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).